Semaglutide Weight Loss Timeline: Month-by-Month Results
On a typical semaglutide weight loss timeline, most people lose 2-5 pounds in the first month of titration, reach 5-10% of their starting weight by months 4-6, and approach an average of about 15% of body weight near 68 weeks at the full maintenance dose (STEP 1 trial, NEJM 2021). That average comes from people who reached and stayed on the 2.4 mg Wegovy dose, so your own curve depends heavily on which dose you are on and how long you have been on it.
Starting a GLP-1 medication like Ozempic or Wegovy is a significant step, and the most common question is simple: when will I actually see results? Every person is different, but clinical trials and the FDA labels give a reliable month-by-month map. This guide lays out that map, explains why the line never falls in a straight diagonal, and shows how to read your own trend instead of comparing yourself to a trial average.
Semaglutide Weight Loss by Month
The table below summarizes a representative timeline. It assumes a standard titration toward a maintenance dose, consistent dosing, and no major changes in health status. Ranges are percentages of starting body weight, which is the more useful unit than raw pounds because it scales with where you began.
| Phase | Typical month | Common dose (Wegovy) | Typical cumulative loss | What's happening |
|---|---|---|---|---|
| Adjustment | Months 1-2 | 0.25-0.5 mg | 1-4% (about 2-5 lbs) | Appetite drops; the body adapts to the drug; loss is modest by design |
| Momentum | Months 3-4 | 1.0-1.7 mg | 4-8% | Satiety becomes stronger; the trend line clearly turns down |
| Acceleration | Months 5-7 | 1.7-2.4 mg | 8-12% | Steady weekly loss at or near maintenance dose |
| Maintenance push | Months 8-12 | 2.4 mg | 10-15% | Loss continues but begins to slow as the body adapts |
| Plateau / set point | Months 12-16+ | 2.4 mg | ~13-16% (avg ~15%) | Loss flattens toward a new set point near the trial average |
These figures track the trajectory reported in the STEP 1 trial, where adults without diabetes on 2.4 mg weekly semaglutide lost an average of about 14.9% of body weight at 68 weeks, versus roughly 2.4% on placebo. The numbers are averages, not promises; verify what is realistic for you with your prescriber. A GLP-1 weight loss tracker that marks each dose change on the curve makes it easy to see how your real loss compares to this shape.
Month 1-2: The Adjustment Phase
During the initial titration period (0.25 mg, then 0.5 mg), most people notice reduced appetite and early satiety before they notice much movement on the scale. Weight loss is typically modest — often 2-5 pounds. The low starting dose is deliberately sub-therapeutic; its job is to let your body acclimate and minimize nausea and other side effects, not to produce dramatic results. If you see a slight downward trend or even just stabilization here, you are on track.
Month 3-4: Momentum Builds
As you titrate to 1.0 mg and 1.7 mg, appetite suppression becomes more pronounced. Many people lose a noticeable 5-10% of their starting weight by the end of month 4, and this is usually when the weight loss chart shows an unmistakable downward slope rather than a wobble. Each dose step typically steepens the trend line, which is why logging your dose changes alongside your weight is so useful.
Month 5-12: The Core of the Curve
This is where the bulk of the loss happens for most people, especially once you reach the 2.4 mg Wegovy maintenance dose. Weekly loss tends to be steadiest in this window, then gradually decelerates as you get closer to your body's new set point. By month 12, average results in trials are in the 10-15% range and still climbing slowly.
Month 12-16+: Approaching the Average
By around 68 weeks, the STEP 1 average lands near 15%. For most people the curve has flattened considerably by this point — not because the medication stopped working, but because weight loss on any intervention naturally slows as the body adapts and the deficit shrinks.
Why Semaglutide Progress Is Not Linear
If you expected to lose the same number of pounds every week, the real data will feel frustrating. Weight loss is not linear, and understanding why prevents you from quitting during a normal slow patch.
Daily noise vs. the true trend
Body weight swings 2-5 pounds day to day from water, sodium, carbohydrate stores, hormonal cycles, and digestion. A single high reading after a salty dinner is noise, not a reversal. The only reliable signal is a smoothed trend line read over weeks, not individual weigh-ins. This is the single most important habit for staying sane on a GLP-1: judge the trend, not the number.
The titration effect
Because the early doses are sub-therapeutic by design, your fastest, most consistent loss usually begins only after you reach a therapeutic dose. The dose escalation schedule in the FDA prescribing information for Wegovy steps you up over roughly four to five months to the 2.4 mg maintenance dose. A slow first two months is not failure — it is the protocol working as intended. Logging each step with the semaglutide tracker makes the titration effect visible: the trend line tends to get steeper after each dose bump.
Metabolic adaptation
As you lose weight, a smaller body burns fewer calories at rest, and metabolic adaptation can lower energy expenditure further. The same intake that produced a deficit at the start can become a maintenance level later. This is the main reason every weight loss curve eventually flattens, even when nothing has gone wrong.
Plateaus on Semaglutide
A plateau where your trend line stays essentially flat for four to six weeks despite consistent dosing is normal and expected, particularly near your set point. Not every flat week is a plateau, though — a few days of unchanged numbers is almost always noise.
Common, fixable contributors to a genuine stall include:
- Not yet at the maintenance dose. A "plateau" on a starting or intermediate dose is often just the medication not working at full strength yet. The next titration step frequently restarts the loss.
- Intake creep. Appetite suppression is strongest early and softens as you adapt. A few hundred extra calories a day can quietly erase a modest deficit.
- Muscle loss. Without enough protein and resistance training, you lose lean mass, which lowers your metabolic rate and stalls the scale.
- Sleep and stress. Short sleep and high stress raise appetite-driving hormones and make adherence harder.
For a full, step-by-step approach, see our guide to breaking a GLP-1 weight loss plateau. The throughline: confirm the stall is real with a trend line first, then change one variable at a time and give each change two to four weeks. Dose changes are always your prescriber's decision, not a DIY adjustment.
Wegovy vs. Ozempic: Same Molecule, Different Maintenance Doses
Ozempic and Wegovy are both semaglutide, but they are dosed and approved differently, which affects the timeline you can realistically expect.
| Ozempic | Wegovy | |
|---|---|---|
| FDA-approved use | Type 2 diabetes | Chronic weight management |
| Maximum / maintenance dose | 2.0 mg weekly | 2.4 mg weekly |
| Trial weight loss reference | ~6-7% (diabetes trials) | ~14.9% at 68 weeks (STEP 1) |
| Typical timeline shape | Slower, lower ceiling | Steeper, higher ceiling |
Because Wegovy titrates to the higher 2.4 mg dose studied in STEP 1 and detailed in the Wegovy label, it generally produces larger average weight loss than Ozempic, whose maintenance dose tops out at 2.0 mg. People are sometimes prescribed Ozempic off-label for weight loss; if you are comparing experiences online, make sure you are comparing the same dose, because a 1.0 mg Ozempic curve and a 2.4 mg Wegovy curve are not the same trajectory. Either way, the molecule is identical, so the early adjustment phase feels much the same.
How OffGrid Dose Helps You Read Your Timeline
A timeline only helps if you can compare it to your own data. OffGrid Dose plots your weight as a smoothed trend, marks every dose change on the curve, and calculates your rate of loss between those markers — so you can see exactly how each titration step affected your results. Its projected goal date uses your actual rate of loss rather than a trial average, which keeps expectations realistic. Everything is stored on your iPhone with no account, no cloud, and no servers, so your weight and dose history stay private to you. See the full weight and dose tracking features for how the trend, dose markers, and projections work together.
Key Takeaways
- The first 1-2 months are slow by design; meaningful loss usually starts after months 3-4 as you reach therapeutic doses.
- Average semaglutide loss is about 15% of body weight near 68 weeks on the 2.4 mg Wegovy maintenance dose.
- Progress is never linear — judge the trend over weeks, not single weigh-ins.
- Plateaus are normal, especially before maintenance dose and near your set point; most are addressable.
- Wegovy (2.4 mg) generally outperforms Ozempic (2.0 mg) on average because of the higher maintenance dose.
Frequently Asked Questions
When does semaglutide start working for weight loss?
Appetite suppression often begins within the first week or two, but visible weight loss is usually modest during the first 1-2 months because the starting doses (0.25-0.5 mg) are intentionally sub-therapeutic. Most people see a clear downward trend by months 3-4 as they titrate to higher doses. If you are tracking a smoothed trend line, you may notice movement before the number on the scale "feels" different.
How much weight will I lose on semaglutide in 3 months?
A common range is roughly 4-8% of starting body weight by month 3, though this varies widely with your dose, starting weight, diet, activity, and genetics. Someone still finishing titration may be on the lower end, while someone who reached a therapeutic dose sooner may be higher. Treat these as averages and confirm realistic goals with your prescriber.
Why am I not losing weight on semaglutide?
The most common reasons are: you have not reached your maintenance dose yet, intake has crept up as appetite suppression softened, you are losing muscle without enough protein and strength training, or you are reacting to daily scale noise that hides a trend still drifting down. Pull up four to six weeks of trend data first to confirm whether you are actually plateaued, then review dose and habits with your clinician. Our plateau guide walks through each lever.
Is the Ozempic and Wegovy weight loss timeline the same?
They share the same active ingredient and a similar early experience, but Wegovy titrates to a higher 2.4 mg maintenance dose and is studied specifically for weight management, so its average results are larger. Ozempic's maintenance dose tops out at 2.0 mg. Compare like-for-like doses when reading other people's results.
Does weight loss stop after a year on semaglutide?
For most people the curve flattens substantially by 12-16 months as the body approaches a new set point, which is why the trial average lands near 15% around 68 weeks rather than continuing indefinitely. Flattening is normal adaptation, not the medication failing. Maintaining your loss typically means staying on the medication and habits with your prescriber's guidance.
This article is for educational purposes only and is not medical advice. Semaglutide dosing, expected results, plateaus, and treatment changes should be discussed with your licensed healthcare provider, and any clinical details should be verified against the official FDA prescribing information for your specific medication.
Related Articles
Track this with OffGrid Dose
Log every dose, rotate injection sites, and watch your weight trend — all private and on-device.
GLP-1 Weight Loss tracker →